Pancreatic Cancer Research

ResearcherYuhuangding HospitalActive in the last 2 years

Laijian Sui

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0617-113X; OpenAlex author ID A5081503171. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Implication of Capillary Morphogenesis Gene 2 (CMG2) in the Disease Progression and Peritoneal Metastasis of Pancreatic Cancer. Co-author DOI 10.3390/cancers16162893↗
  2. Expression of Death Associated Proteins DAP1 and DAP3 in Human Pancreatic Cancer. Co-author DOI 10.21873/anticanres.15010↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lin Ye · 2 shared papers, 2021–2024 · strength 0.34
  2. Chunyi Hao · 2 shared papers, 2021–2024 · strength 0.34
  3. Wen G. Jiang · 2 shared papers, 2021–2024 · strength 0.34
  4. Ziqian Fang · 1 shared paper, 2024 · strength 0.19
  5. Bilal A. Al-Sarireh · 1 shared paper, 2024 · strength 0.19
  6. Yiming Yang · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.